HPV16 E7 DNA tattooing: safety, immunogenicity, and clinical response in patients with HPV-positive vulvar intraepithelial neoplasia

Samuels, S.; Heeren, A.M.; Zijlmans, H.J.M.A.A.; Welters, M.J.P.; Berg, J.H. van den; Philips, D.; ... ; Kenter, G.G. (2017)

Article / Letter to editor

• VIN
• HPV
• Immunotherapy
• DNA vaccine
• Immunogenicity
• Safety

• All authors: Samuels, S.; Heeren, A.M.; Zijlmans, H.J.M.A.A.; Welters, M.J.P.; Berg, J.H. van den; Philips, D.; Kvistborg, P.; Ehsan, I.; Scholl, S.M.E.; Nuijen, B.; Schumacher, T.N.M.; Beurden, M. van; Jordanova, E.S.; Haanen, J.B.A.G.; Burg, S.H. van der; Kenter, G.G.
• Date: 2017-09-30
• Journal: Cancer Immunology, Immunotherapy
• Volume: 66
• Issue: 9
• Pages: 1163 - 1173
• DOI: doi:10.1007/s00262-017-2006-y